Stockreport

Corcept Gains FDA Approval In Ovarian Cancer (Rating Upgrade) [Seeking Alpha]

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors
PDF Lifyorli demonstrated a 35% reduction in risk of death and strong tolerability, positioning CORT as a new oncology leader in ovarian cancer. Analyst consensus sees Li [Read more]